Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06638996 · ClinicalTrials.gov registry record · NA

Acute Psychological and Physiological Effects of Cannabigerol

A NA study of No Disease or Condition is Being Studied, sponsored by Washington State University.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT06638996 is a NA study of No Disease or Condition is Being Studied that is actively recruiting participants, run by Washington State University. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06638996, a NA study of No Disease or Condition is Being Studied, is actively recruiting participants, sponsored by Washington State University.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine the acute effects of cannabigerol (CBG) on various psychological (e.g., anxiety, stress, mood, memory, impairment, intoxication, side effects) and physiological (blood pressure, cortisol, heart rate variability, electrodermal activity, pain tolerance, temperature) outcomes. Further, potential side effects of CBG (sleepiness/fatigue, dry mouth/eyes, increased appetite, and dizziness nausea) will be assessed. As such, the study is focused on better understanding some of the potentially beneficial and detrimental effects of CBG on humans.

Interventions

  • DIETARY_SUPPLEMENT CBG Intervention
  • OTHER Placebo Intervention

Study Locations (1)

Washington

  • Washington State University - Pullman Campus - Pullman

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2024-10-28
Est. Completion 2026-10-31
Phase NA

Sponsor

Washington State University

64 total trials

What the Registry Record Tells You About NCT06638996

The ClinicalTrials.gov registry entry for NCT06638996 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington State University, which has 64 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with No Disease or Condition is Being Studied appearing as the primary indexed condition, and to 2 interventions - of which CBG Intervention is the first listed.

NCT06638996 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT06638996 about?

NCT06638996 is a clinical study titled "Acute Psychological and Physiological Effects of Cannabigerol". The purpose of this study is to examine the acute effects of cannabigerol (CBG) on various psychological (e.g., anxiety, stress, mood, memory, impairment, intoxication, side effects) and physiological (blood pressure, cortisol, heart rate variability, electrodermal activity, pain tolerance, temperat...

What is the current status of trial NCT06638996?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-10-28. Estimated completion is 2026-10-31.

What conditions does trial NCT06638996 study?

This clinical trial studies the following conditions: No Disease or Condition is Being Studied.

What interventions are being tested in trial NCT06638996?

The interventions under investigation include: CBG Intervention (DIETARY_SUPPLEMENT), Placebo Intervention (OTHER).

Who is sponsoring clinical trial NCT06638996?

This trial is sponsored by Washington State University, which has 64 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06638996 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for No Disease or Condition is Being Studied

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.